#PaperoftheDay: "GZ17-6.02 and palbociclib interact to kill ER+ breast cancer cells" https://t.co/hdX5SqJhU7 #breastcancer #oncology #science #opencaccess #medEd #OA
RT @Oncotarget: #PaperoftheDay: "GZ17-6.02 and palbociclib interact to kill ER+ breast cancer cells" https://t.co/0pnCqZfEC3 #breastcancer…
#PaperoftheDay: "GZ17-6.02 and palbociclib interact to kill ER+ breast cancer cells" https://t.co/0pnCqZfEC3 #breastcancer #oncology #science #opencaccess #medEd #OA
GZ17-6.02 and palbociclib interact to kill ER+ breast cancer cells #lymphoma #lymsm https://t.co/CC6RqRDucQ
GZ17-6.02 and palbociclib interact to kill ER+ breast cancer cells #lymphoma #lymsm https://t.co/rdrX1RAl6s
RT @Oncotarget: NEW #PaperoftheDay: "GZ17-6.02 and palbociclib interact to kill ER+ breast cancer cells" https://t.co/0pnCqZfEC3 #breastcan…
NEW #PaperoftheDay: "GZ17-6.02 and palbociclib interact to kill ER+ breast cancer cells" https://t.co/0pnCqZfEC3 #breastcancer #oncology #science #opencaccess #medEd #OA